Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
Recurrence of Intracranial Tumors following Adoptive T Cell Therapy Can Be Prevented by Direct and Indirect Killing Aided by High Levels of Tumor Antigen Cross-Presented on Stromal Cells
Journal of Immunology, 07/27/09
Thomas DL et al. – Targeting brain tumor stroma or increasing Ag shedding from tumor cells to enhance cross–presentation may improve the clinical success of T cell adoptive therapies.
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
IL-13 from Th2-type cells suppresses induction of antigen-specific Th1 immunity in a T-cell lymphoma
International Immunology, 12/03/09
Prioritization of cancer antigens: keeping the target in sight
Expert Review of Vaccines, 12/02/09
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
Clinical Cancer Research, 12/01/09
Today in Neurologic/Ophthalmic...keeping you current
Receive free subspecialty "5-minute updates" via email
Immunologic Paradox in the Diagnosis of Tuberculous Meningitis
Clinical and Vaccine Immunology, 12/02/09
SLAT/Def6 Plays a Critical Role in the Development of Th17 Cell-Mediated Experimental Autoimmune Encephalomyelitis
Journal of Immunology, 12/01/09
Efficient serum clearance of botulinum neurotoxin using a pool of small antitoxin binding agents
Infection and Immunity, 11/30/09
Sponsor
Article Search
Sponsor


See Latest Articles


